Hypercalcemia in a patient with autoimmune polyglandular syndrome

  • Svetlana Katsnelson | Svetlana.Katsnelson@sbumed.org Department of Medicine, Stony Brook University Medical Center, Stony Brook, NY, United States.
  • Jessica Cella Department of Medicine; Division of Endocrinology and Metabolism, Stony Brook University Medical Center, Stony Brook, NY, United States.
  • Heesuk Suh Department of Medicine; Division of Nephrology, Stony Brook University Medical Center, Stony Brook, NY, United States.
  • Marina M. Charitou Department of Medicine; Division of Endocrinology and Metabolism, Stony Brook University Medical Center, Stony Brook, NY, United States.

Abstract

Hypercalcemia is a rare condition in patients with autoimmune polyglandular syndrome (APS-1), usually characterized by hypoparathyroidism and hypocalcemia, and it can develop due to simultaneous adrenal insufficiency. We present a case of severe hypercalcemia in a patient with APS-1, found to have adrenal insufficiency secondary to steroid non-compliance.

Google Scholar

Google Scholar

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2012-04-04
Info
Issue
Section
Case Reports
Keywords:
hypercalcemia, auto-immune polyglandular syndrome, adrenal insufficiency.
Statistics
  • Abstract views: 801

  • PDF: 486
  • HTML: 75
How to Cite
Katsnelson, S., Cella, J., Suh, H., & Charitou, M. M. (2012). Hypercalcemia in a patient with autoimmune polyglandular syndrome. Clinics and Practice, 2(2), e39. https://doi.org/10.4081/cp.2012.e39